These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21883376)

  • 1. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
    Mori F; Tanji K; Kon T; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Yoshida M; Wakabayashi K
    Neuropathol Appl Neurobiol; 2012 Jun; 38(4):322-8. PubMed ID: 21883376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
    Mori F; Tanji K; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Kamitani T; Yoshida M; Wakabayashi K
    Pathol Int; 2012 Jun; 62(6):407-11. PubMed ID: 22612509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
    Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease.
    Woulfe J; Gray DA; Mackenzie IR
    Brain Pathol; 2010 May; 20(3):589-97. PubMed ID: 19832837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.
    Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
    Acta Neuropathol; 2011 Feb; 121(2):219-28. PubMed ID: 20886222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of basophilic inclusions and FUS-immunoreactive neuronal and glial inclusions in a case of familial amyotrophic lateral sclerosis.
    Kobayashi Z; Tsuchiya K; Arai T; Aoki M; Hasegawa M; Ishizu H; Akiyama H; Mizusawa H
    J Neurol Sci; 2010 Jun; 293(1-2):6-11. PubMed ID: 20409561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.
    Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP
    Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incipient intranuclear inclusion body disease in a 78-year-old woman.
    Mori F; Miki Y; Tanji K; Ogura E; Yagihashi N; Jensen PH; Wakabayashi K
    Neuropathology; 2011 Apr; 31(2):188-93. PubMed ID: 20667015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis.
    Liu Y; Mimuro M; Yoshida M; Hashizume Y; Niwa H; Miyao S; Ujihira N; Akatsu H
    Acta Neuropathol; 2008 Dec; 116(6):615-23. PubMed ID: 18923837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease.
    Mori F; Tanji K; Miki Y; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2018 Jan; 662():389-394. PubMed ID: 29100804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUS pathology in basophilic inclusion body disease.
    Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
    Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numerous FUS-positive inclusions in an elderly woman with motor neuron disease.
    Fujita Y; Fujita S; Takatama M; Ikeda M; Okamoto K
    Neuropathology; 2011 Apr; 31(2):170-6. PubMed ID: 20667018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain.
    Aoki N; Higashi S; Kawakami I; Kobayashi Z; Hosokawa M; Katsuse O; Togo T; Hirayasu Y; Akiyama H
    Acta Neuropathol; 2012 Sep; 124(3):383-94. PubMed ID: 22526020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease.
    Sone J; Tanaka F; Koike H; Inukai A; Katsuno M; Yoshida M; Watanabe H; Sobue G
    Neurology; 2011 Apr; 76(16):1372-6. PubMed ID: 21411744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.
    Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pathological subtypes of FTLD-FUS.
    Mackenzie IR; Munoz DG; Kusaka H; Yokota O; Ishihara K; Roeber S; Kretzschmar HA; Cairns NJ; Neumann M
    Acta Neuropathol; 2011 Feb; 121(2):207-18. PubMed ID: 21052700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases.
    Kon T; Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Feb; 34(1):19-26. PubMed ID: 23888880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases.
    Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variability within the inclusion body spectrum of basophilic inclusion body disease and neuronal intermediate filament inclusion disease in frontotemporal lobar degenerations with FUS-positive inclusions.
    Gelpi E; Lladó A; Clarimón J; Rey MJ; Rivera RM; Ezquerra M; Antonell A; Navarro-Otano J; Ribalta T; Piñol-Ripoll G; Pérez A; Valldeoriola F; Ferrer I
    J Neuropathol Exp Neurol; 2012 Sep; 71(9):795-805. PubMed ID: 22892522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions.
    Matsuoka T; Fujii N; Kondo A; Iwaki A; Hokonohara T; Honda H; Sasaki K; Suzuki SO; Iwaki T
    Neuropathology; 2011 Feb; 31(1):71-6. PubMed ID: 20573033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.